COVID-19 Risk Reduction Among African American Parishioners
NCT ID: NCT04542343
Last Updated: 2024-05-22
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
405 participants
INTERVENTIONAL
2021-06-01
2022-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Improving the Collaborative Health of Minority COVID-19 Survivor and Carepartner Dyads
NCT05370014
We Can Prevent Diabetes: A Behavioral Intervention to Reduce Diabetes Risk in African Americans
NCT01227473
The Church as a Bridge to Deliver Health Resources Via Telehealth
NCT02773069
Church-based Health Intervention to Eliminate Racial Inequalities in Cardiovascular Health
NCT06065098
Addressing Vaccine Hesitancy and Increasing COVID-19 Vaccine Uptake Among African American Young Adults in the South
NCT05490329
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Risk Reduction of COVID-19 Among African American Parishioners
This arm will implement "one group pretest-posttest" design to improve COVID associated health outcomes of AA older parishioners in collaboration with trained young church-based health educators.
Change in knowledge, motivation, skills, resources
Provide/enhance knowledge, modify attitudes, motivate and provide skills and resources to reduce COVID-19 related risk and challenges.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Change in knowledge, motivation, skills, resources
Provide/enhance knowledge, modify attitudes, motivate and provide skills and resources to reduce COVID-19 related risk and challenges.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have at least one risk factor for COVID-19
Exclusion Criteria
* Cognitive deficit (identified by short version of mini-mental instrument)
* Does not self-identify as African American and/or Black
* Under the age of 55years
* Unable to speak and/or read English
55 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Minority Health and Health Disparities (NIMHD)
NIH
Charles Drew University of Medicine and Science
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mohsen Bazargan, PhD
Role: PRINCIPAL_INVESTIGATOR
Charles R. Drew University of Medicine & Science
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Charles R. Drew University of Medicine & Science
Los Angeles, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
COVID19Church
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.